Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy

被引:20
|
作者
Diedrich, Chantal M. [1 ]
Kastelein, Arnoud W. [1 ]
Verri, Filippo M. [1 ]
Weber, Maaike A. [1 ]
Ince, Can [2 ,3 ]
Roovers, Jan-Paul W. R. [1 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam UMC, Dept Translat Physiol, Amsterdam, Netherlands
[3] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands
关键词
estrogen; imaging; microcirculation; vulvovaginal atrophy;
D O I
10.1002/nau.23977
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims This study aims to assess vaginal wall angioarchitecture and function in women with vulvovaginal atrophy (VVA) and determine the effect of topical estrogen on the vaginal microcirculation. Materials and Methods In this prospective observational study, incident dark field imaging was used to assess the vaginal microcirculation. In patients with VVA, measurements were performed before and after treatment with topical estrogen and compared to measurements performed in women without VVA. Vaginal angioarchitecture was studied by assessing microcirculatory architecture and capillary tortuosity scores at four regions of the vaginal wall. In addition, the capillary density and microvascular flow index (MFI) were obtained. Results Seventeen women were included in this study. Of these, eight women were diagnosed with VVA and nine women were considered healthy controls. Significant differences were observed between groups with regard to microcirculatory architecture scores. The architecture of the microvasculature in women with VVA was characterized by the appearance of a vascular network without capillary loops, whereas an array of capillary loops was predominantly seen in women without VVA. After estrogen treatment, no difference in architecture scores between patients and healthy controls was observed. Capillary tortuosity, capillary density, and MFI were similar in both groups before and after estrogen treatment. Conclusions The architecture of vaginal microvasculature is altered in patients with VVA. In case of similar vascular architecture, capillary tortuosity and density seem to be comparable. Treatment with topical estrogen results in restoration of the angioarchitecture.
引用
收藏
页码:1298 / 1304
页数:7
相关论文
共 50 条
  • [21] Menopausal vulvovaginal atrophy: comparative effectiveness of vaginal therapies
    Fernandes, Tatiane
    Pedro, Adriana O.
    Baccaro, Luiz F.
    Costa-Paiva, Lucia S.
    Pinto-Neto, Aarao M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1388 - 1388
  • [22] Local Estrogen or Systemic Opsemifene for Treatment of Vulvovaginal Atrophy and Their Effects on Mammographic Density
    Zuo, Stephanie W.
    Wu, Harold
    Shen, Wen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1406 - 1407
  • [23] Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy
    Chuery, A. C. S.
    de Gois Speck, N. M.
    de Moura, K. F. Q.
    Belfort, P. N.
    Sakano, C.
    Ribalta, J. C. L.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2011, 38 (02): : 143 - 145
  • [24] Vulvovaginal atrophy in women after cancer
    Cox, P.
    Panay, N.
    CLIMACTERIC, 2019, 22 (06) : 565 - 571
  • [25] Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis
    Shen, Jian
    Song, Ning
    Williams, Christopher J.
    Brown, Celeste J.
    Yan, Zheng
    Xu, Chen
    Forney, Larry J.
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis
    Jian Shen
    Ning Song
    Christopher J. Williams
    Celeste J. Brown
    Zheng Yan
    Chen Xu
    Larry J. Forney
    Scientific Reports, 6
  • [27] Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women
    Bachmann, Gloria A.
    Schaefers, Matthias
    Uddin, Alkaz
    Utian, Wulf H.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (05): : 877 - 882
  • [28] SAFETY AND EFFICACY OF OSPEMIFENE, A SELECTIVE ESTROGEN RECEPTOR MODULATOR, FOR TREATEMENT OF POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY
    Portman, David
    Simon, James
    Goldstein, Steven
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 165 - 165
  • [29] One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy
    Portman, David
    Shulman, Lee
    Yeaw, Jason
    Zeng, Sha
    Uzoigwe, Chioma
    Maamari, Ricardo
    Iyer, Neeraj N.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (11): : 1197 - 1203
  • [30] Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
    Kingsberg, S. A.
    Kellogg, S.
    Krychman, M.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 105 - 111